Same Indication

Methylprednisolone vs Pembrolizumab

Methylprednisolone vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Methylprednisolone and Pembrolizumab.

Mechanism of Action

Methylprednisolone: Intermediate-acting synthetic glucocorticoid.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Methylprednisolone — 18-36 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Methylprednisolone — C22H30O5.

Molecular Weight: Methylprednisolone — 374.4710 g/mol.

Type: Methylprednisolone — Small molecule; Pembrolizumab — Antibody.